Clinical
Trials
Finder
Conditions
Locations
Institutions
Search Trials
Search
Conditions
Locations
Institutions
Search Trials
Institutions
CIMCA ( Site 0551)
CIMCA ( Site 0551)
San José, Provincia de San José, Costa Rica
1 recruiting
Showing
1–1
of
1
trials
Recruiting
Phase 3
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Breast Neoplasms
Merck Sharp & Dohme LLC
1,200 enrolled
257 locations
NCT06312176
Feedback